The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Sardesai Niranjan since 2012.
The trader's CIK number is 1464547.
At the time of the last reporting, Sardesai Niranjan was the Chief Operating Officer of Inovio Pharmaceuticals, Inc.. (stock ticker symbol INO).
Also see all insider trading activities at Inovio Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | INO | 0 | $0 | 0 | $0 | 53,767 | $0 |
| 2017 | INO | 0 | $0 | 0 | $0 | 40,890 | $60,055 |
| 2016 | INO | 0 | $0 | 21,800 | $202,740 | 41,450 | $202,669 |
| 2015 | INO | 4,000 | $22,000 | 0 | $0 | 0 | $0 |
| 2014 | INO | 2,550 | $22,185 | 0 | $0 | 0 | $0 |
| 2013 | INO | 25,000 | $13,325 | 0 | $0 | 0 | $0 |
| 2012 | INO | 10,000 | $4,500 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-03-09 | INO | Option Ex | 25,000 | .00 | 0 |
| 2018-03-10 | INO | Option Ex | 20,434 | .00 | 0 |
| 2018-03-05 | INO | Option Ex | 8,333 | .00 | 0 |
| 2017-03-09 | INO | Option Ex | 25,000 | .00 | 0 |
| 2017-03-10 | INO | Option Ex | 6,077 | .00 | 0 |
| 2017-01-04 | INO | Option Ex | 9,813 | 6.12 | 60,055 |
| 2016-08-28 | INO | Option Ex | 33,116 | 6.12 | 202,669 |
| 2016-08-29 | INO | Sale | 21,800 | 9.30 | 202,740 |
| 2016-03-05 | INO | Option Ex | 8,334 | .00 | 0 |
| 2015-09-30 | INO | Buy | 4,000 | 5.50 | 22,000 |
| 2014-08-12 | INO | Buy | 2,550 | 8.70 | 22,185 |
| 2013-03-20 | INO | Buy | 25,000 | .53 | 13,325 |
| 2012-05-16 | INO | Buy | 10,000 | .45 | 4,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sardesai Niranjan (Chief Operating Officer of Inovio Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.